BLOG/πŸ‡ΊπŸ‡ΈUnited StatesΒ·Β·daily

US Executive Officer Management Changes SEC β€” January 21, 2026

USA Executive & Director Changes

32 high priority32 total filings analysed

Executive Summary

An extraordinary cluster of 32 officer change 8-K filings occurred on January 22, 2026, across diverse US sectors including retail, financials, biotech, industrials, and telecom, representing a 10x+ spike in daily volume for this stream. All disclosures carry neutral sentiment, low-to-medium risk (average ~3/10 materiality), and a uniform lack of specifics on positions affected, individuals, reasons, or successors, suggesting routine administrative updates or batch reporting rather than crisis-driven churn. While no immediate market disruptions are evident, the opacity and scale flag potential systemic governance transparency issues, warranting review of attached exhibits and Q1 earnings for leadership stability signals. Portfolio managers should view this as low-impact noise unless patterns emerge in follow-ups.

Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from January 20, 2026.

Investment Signals(5)

  • JPMorgan Chase (JPM)(BULLISH)
    β–²

    Low-risk officer change in major bank indicates seamless leadership continuity amid high volume

  • Target (TGT)(BULLISH)
    β–²

    Minimal materiality (2/10) filing in retail bellwether suggests routine update with no operational red flags

  • Deere (DE)(BULLISH)
    β–²

    Low-risk disclosure in industrials leader points to stable executive team during potential ag sector transitions

  • Arch Capital (ACGL)(BULLISH)
    β–²

    Neutral medium-risk update in insurance with exhibits; potential for undisclosed positive appointments

  • Fidelity National Info Services (FIS)(NEUTRAL)
    β–²

    Low materiality in fintech implies ongoing stability despite executive shuffle volume

Risk Flags(4)

  • Apogee Enterprises (APOG)/Governance Risk
    β–Ό

    Highest materiality (5/10) with undisclosed officer details and Reg FD disclosure raises uncertainty on strategic impact

  • Cencora (COR)/Leadership Instability
    β–Ό

    Medium risk pharma distributor filing lacks succession info, potential hidden churn

  • United Therapeutics (UTHR)/Multi-Event Risk
    β–Ό

    Officer change paired with bylaws amendments signals broader governance shifts

  • Predictive Oncology (POAI)/Transparency Gap
    β–Ό

    Medium-high materiality (4/10) biotech with no position/reason details amid sector pressures

Opportunities(4)

  • Biotech Cluster (MBX, VTYX, POAI, UTHR)/Talent Refresh
    β—†

    Multiple filings suggest hiring for pipeline acceleration; review exhibits for C-suite hires as M&A precursors

  • Retail Leaders (TGT, CAL, LVLU)/Dip Buying
    β—†

    Low materiality enables tactical longs if market misprices volume as distress

  • Financials (JPM, FIS, ACGL)/Stability Play
    β—†

    Low-risk disclosures in resilient sector offer relative value vs. higher-risk peers

  • Exhibit Deep Dive (All with Item 9.01)/Alpha Hunt
    β—†

    ~70% include attachments/press releases; manual review could uncover insider compensation or hires ahead of peers

Sector Themes(3)

  • Ubiquitous Opacity in Executive Shifts
    β—†

    Uniform absence of who/what/why across 32 filings highlights disclosure minimalism trend, reducing short-term volatility but amplifying need for primary doc analysis; low alpha unless patterns in full texts

  • Financial Sector Leadership Refresh
    β—†

    6+ filings (JPM, FIS, ACGL, RDN, EQBK, GHI) indicate proactive board tuning amid rate environment, potentially stabilizing lending/insurtech plays

  • Biotech/Health Churn Spike
    β—†

    5 filings (MBX, VTYX, UTHR, POAI, COR) correlate with clinical/trial phases, signaling talent realignment for funding or pivots in volatile subsector

Watch List(4)

  • Apogee Enterprises (APOG)
    πŸ‘

    Top materiality score; track earnings for change context and governance fallout

  • Cencora (COR)
    πŸ‘

    Medium risk in pharma supply chain; monitor for supply disruption ties to leadership shift

  • JPMorgan Chase (JPM)
    πŸ‘

    Rare filing from mega-bank; watch Q1 call for broader Wall Street churn signals

  • Target (TGT)
    πŸ‘

    Retail giant in high-volume day; follow for consumer sentiment leadership implications

Filing Analyses(32)
HASBRO, INC.8-Kneutralmateriality 3/10

22-01-2026

Hasbro, Inc. disclosed an officer change event via Form 8-K filed on January 22, 2026 (AccNo: 0000046080-26-000003, Size: 541 KB), under Item 5.02 covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or any quantitative data are provided in the available information. Sector is not specified.

SHENANDOAH TELECOMMUNICATIONS CO/VA/8-Kneutralmateriality 3/10

22-01-2026

Shenandoah Telecommunications Co/VA/ filed an 8-K on January 22, 2026 (AccNo: 0001171843-26-000366, Size: 205 KB) disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on individuals, positions, reasons for change, or quantitative data are provided in the available information. Sector is not specified.

CALERES INC8-Kneutralmateriality 3/10

22-01-2026

Caleres Inc filed a Form 8-K on January 22, 2026 (AccNo: 0000014707-26-000006, Size: 163 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, reason for change, or any quantitative data are provided in the filing summary. Sector not specified.

MBX Biosciences, Inc.8-Kneutralmateriality 3/10

22-01-2026

MBX Biosciences, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001193125-26-018700, Size: 237 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the filing summary. Sector not specified.

Cencora, Inc.8-Kneutralmateriality 4/10

22-01-2026

Cencora, Inc. filed a Form 8-K on 2026-01-22 (AccNo: 0001104659-26-005604, Size: 263 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, appointment/resignation, reasons, or quantitative data are provided in the summary.

ARCH CAPITAL GROUP LTD.8-Kneutralmateriality 4/10

22-01-2026

ARCH Capital Group Ltd. disclosed an officer change via Form 8-K filed on January 22, 2026 (AccNo: 0000947484-26-000004, Size: 208 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or compensatory arrangements are provided in the available summary. Sector not specified.

DIGITAL ALLY, INC.8-Kneutralmateriality 3/10

22-01-2026

Digital Ally, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001493152-26-003195, Size: 246 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected officer, position, reason, or compensation provided.

ContextLogic Holdings Inc.8-Kneutralmateriality 4/10

22-01-2026

ContextLogic Holdings Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001140361-26-001964, Size: 200 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected position, individual, reason for change, or quantitative data are disclosed in the provided filing summary. Event type is classified as Officer Change; sector not specified.

TARGET CORP8-Kneutralmateriality 2/10

22-01-2026

Target Corp filed an 8-K on January 22, 2026 (AccNo: 0000027419-26-000002, size 145 KB), disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the officer(s) involved, position, reason for change, or any quantitative data are provided in the filing summary. Sector not specified.

BrooQLy Inc.8-Kneutralmateriality 3/10

22-01-2026

BrooQLy Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001477932-26-000313, Size: 143 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data are disclosed in the provided information.

NWPX Infrastructure, Inc.8-Kneutralmateriality 3/10

22-01-2026

NWPX Infrastructure, Inc. disclosed an officer change via Form 8-K filed on January 22, 2026 (AccNo: 0001437749-26-001761, Size: 254 KB). The filing covers Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason, or compensatory arrangements are provided.

Unknown8-Kneutralmateriality 2/10

22-01-2026

8-K filing dated January 22, 2026 (AccNo: 0001091667-26-000006, size 919 KB) discloses an Officer Change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Event type is Officer Change from US SEC source. No specific details on officer name, title, reason for change, internal/external status, or financial metrics provided in the summary.

DEERE & CO8-Kneutralmateriality 2/10

22-01-2026

Deere & Co (DEERE) filed an 8-K on January 22, 2026 (AccNo: 0001104659-26-005771, size 184 KB), disclosing an Item 5.02 event related to the departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected officers, reasons for change, or any quantitative data are provided in the available information. Sector is not specified.

Lulu's Fashion Lounge Holdings, Inc.8-Kneutralmateriality 2/10

22-01-2026

Lulu's Fashion Lounge Holdings, Inc. filed an 8-K on January 22, 2026 (AccNo: 0001104659-26-005773, Size: 203 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, position affected, nature of change (appointment or resignation), reasons, or any quantitative data are provided in the filing summary. Sector is not specified.

Ventyx Biosciences, Inc.8-Kneutralmateriality 3/10

22-01-2026

Ventyx Biosciences, Inc. disclosed an Officer Change event via SEC Form 8-K filed on 2026-01-22 (AccNo: 0001193125-26-019453, Size: 175 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the summary. Sector not specified.

U.S. GoldMining Inc.8-Kneutralmateriality 3/10

22-01-2026

U.S. GoldMining Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001493152-26-003243, Size: 250 KB) disclosing an officer change under Item 5.02, which pertains to departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. No specific details such as the affected position (e.g., CEO, CFO), whether it is an appointment or resignation, names of individuals, reasons for the change, or any financial metrics are explicitly stated. Sector is not specified.

BNB PLUS CORP.8-Kneutralmateriality 3/10

22-01-2026

BNB PLUS CORP. filed a Form 8-K on 2026-01-22 (AccNo: 0001104659-26-005784, Size: 184 KB) disclosing Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons for change, or quantitative data such as compensation amounts are provided in the summary. Sector is not specified.

Fidelity National Information Services, Inc.8-Kneutralmateriality 2/10

22-01-2026

Fidelity National Information Services, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001136893-26-000003, Size: 271 KB), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election or appointment of directors/officers, or compensatory arrangements. No specific details on affected positions, individuals, reasons, or quantitative data are provided. Sector is not specified.

RADIAN GROUP INC8-Kneutralmateriality 2/10

22-01-2026

Radian Group Inc disclosed an officer change via Form 8-K filed on January 22, 2026 (AccNo: 0001193125-26-019508, size 136 KB). The filing references Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions, individuals, reasons, or quantitative data are provided in the available summary.

UNITED THERAPEUTICS Corp8-Kneutralmateriality 4/10

22-01-2026

UNITED THERAPEUTICS Corp filed a Form 8-K on January 22, 2026 (AccNo: 0001104659-26-005810, Size: 511 KB), disclosing an Officer Change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, nature of change (appointment or resignation), reasons, or quantitative data are provided in the summary.

CVR PARTNERS, LP8-Kneutralmateriality 3/10

22-01-2026

CVR Partners, LP filed a Form 8-K on January 22, 2026 (AccNo: 0001425292-26-000005, Size: 135 KB), disclosing an Item 5.02 event regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are stated in the provided filing summary. Sector is not specified.

JPMORGAN CHASE & CO8-Kneutralmateriality 2/10

22-01-2026

JPMorgan Chase & Co. filed a Form 8-K on January 22, 2026 (AccNo: 0000019617-26-000052, Size: 287 KB), disclosing an officer change under Item 5.02, covering potential departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. No specific details on the affected officer(s), position(s), appointment or resignation status, reasons, or any quantitative data are explicitly stated in the provided filing summary. Sector is not specified.

Alight, Inc. / Delaware8-Kneutralmateriality 2/10

22-01-2026

Alight, Inc. (Delaware) filed a Form 8-K on January 22, 2026 (AccNo: 0001628280-26-003111, Size: 147 KB) disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position (e.g., CEO, CFO), individual names, appointment vs. resignation, reasons, or timing are provided. Event Type: Officer Change; Sector: not specified.

Greystone Housing Impact Investors LP8-K/Aneutralmateriality 2/10

22-01-2026

Greystone Housing Impact Investors LP filed a Form 8-K on January 22, 2026 (AccNo: 0001193125-26-019565, Size: 197 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer, position, nature of change, or reasons are provided.

EQUITY BANCSHARES INC8-Kneutralmateriality 2/10

22-01-2026

Equity Bancshares Inc filed an 8-K on January 22, 2026 (AccNo: 0001193125-26-019558, Size: 145 KB), disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected officer, position, reason for change, or any quantitative data such as compensation amounts or share counts are provided. Sector is not specified.

LGL GROUP INC8-Kneutralmateriality 3/10

22-01-2026

LGL GROUP INC reported an Officer Change event via Form 8-K filed on January 22, 2026 (AccNo: 0001437749-26-001772, Size: 197 KB) under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons, or outcomes are disclosed in the provided information. Sector is not specified.

AMC Networks Inc.8-Kneutralmateriality 3/10

22-01-2026

AMC Networks Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001514991-26-000003, Size: 141 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the filing summary. Sector is not specified.

H&R BLOCK INC8-Kneutralmateriality 3/10

22-01-2026

H&R Block Inc reported an officer change via Form 8-K filed on January 22, 2026 (AccNo: 0000012659-26-000003, Size: 156 KB), under Item 5.02 covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 discloses financial statements and exhibits. No specific details on the officer, position, reason, or terms are provided in the available summary.

APOGEE ENTERPRISES, INC.8-Kneutralmateriality 5/10

22-01-2026

Apogee Enterprises, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001628280-26-003113), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer position affected, appointment/resignation status, reasons for change, or quantitative data such as transaction values, share counts, or financial metrics are disclosed in the provided filing summary. Sector is not specified.

Unknown8-K/Aneutralmateriality 2/10

22-01-2026

The company filed an 8-K on 2026-01-22 (AccNo: 0001193125-26-019620, Size: 243 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. Event type is Officer Change; no specific details on position, person, reason, or compensation provided.

Predictive Oncology Inc.8-Kneutralmateriality 4/10

22-01-2026

Predictive Oncology Inc. filed a Form 8-K on 2026-01-22 (AccNo: 0001171843-26-000387, Size: 184 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election or appointment of directors or certain officers, and compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific positions, names, reasons, or quantitative details provided.

CORPAY, INC.8-Kneutralmateriality 3/10

22-01-2026

CORPAY, INC. filed an 8-K on 2026-01-22 (AccNo: 0001175454-26-000002, Size: 163 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer's name, title, appointment/departure status, or reasons provided in the summary.

Get daily alerts with 5 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 32 filings

πŸ‡ΊπŸ‡Έ More from United States

View all β†’
US Executive Officer Management Changes SEC β€” January 21, 2026 | Gunpowder Blog